These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28207087)

  • 21. Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression.
    Yano K; Kajiya K; Ishiwata M; Hong YK; Miyakawa T; Detmar M
    J Invest Dermatol; 2004 Jan; 122(1):201-8. PubMed ID: 14962109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
    Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
    Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Thrombospondin-2 and FGF-2 in Patients with Advanced Non-small Cell Lung Cancer: Correlation with Survival.
    Naumnik W; Ossolińska M; Płońska I; Chyczewska E; Nikliński J
    Adv Exp Med Biol; 2015; 833():9-14. PubMed ID: 25298262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
    Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
    Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer.
    Tas F; Duranyildiz D; Soydinc HO; Cicin I; Selam M; Uygun K; Disci R; Yasasever V; Topuz E
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):721-5. PubMed ID: 17554539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of angiogenic regulators and skeletal muscle capillarity in selectively bred high aerobic capacity mice.
    Audet GN; Meek TH; Garland T; Olfert IM
    Exp Physiol; 2011 Nov; 96(11):1138-50. PubMed ID: 21804139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
    Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
    Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF.
    Horiguchi H; Jin L; Ruebel KH; Scheithauer BW; Lloyd RV
    Endocrine; 2004 Jul; 24(2):141-6. PubMed ID: 15347840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
    Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
    Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
    Zhang YW; Su Y; Volpert OV; Vande Woude GF
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12718-23. PubMed ID: 14555767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
    Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
    Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic protein kinase Cα inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation.
    Moncada de la Rosa C; Radziwon-Balicka A; El-Sikhry H; Seubert J; Ruvolo PP; Radomski MW; Jurasz P
    J Pharmacol Exp Ther; 2013 Apr; 345(1):15-24. PubMed ID: 23386249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.